detox

An introduction to the importance of artificial urine solutions, highlighting the need for dependable products across various scenarios. We’ll elucidate the process of presenting substitute urine during drug testing. We’ll also cover the comprehensive instructions provided by Quick Fix Synthetic Urine, along with expert tips for discreet usage. Quick Fix Synthetic Urine is intricate and […]

Address of the congress centre Lille Grand Palais:  1 Boulevard des Cités Unies, 59777 Lille  www.lillegrandpalais.com/  +33 (0)3 20 14 15 16 Point of contact for the conference aspects: M. Mickael NAASSILA Professeur des universités Directeur unité INSERM 1247 (ex-ERi24) – GRAP Président de la Société française d’alcoologie  +33 (0)3 22 82 76 72  [email protected]

Registration fees: Early fee Late fee Regular (non-member) € 550.00 € 650.00 Regular (ESBRA member) € 450.00 € 550.00 Student € 220.00 € 320.00 Accompanying person* € 150.00 € 150.00 Prices include French VAT (20%). * Accompanying person fee includes the welcome reception and the gala dinner ; no access to the conferences or the

Keep in touch with the ESBRA 2019 community with the app dedicated to the conference. To access to the Vertcom App, just flash the QR code on your smartphone or download the app from one of the available stores: AppStore GooglePlay Open the Vertcom App and select the event ESBRA 2022. Enjoy!

Sebastian MUELLER Tomas ZIMA Marcin WOJNAR Joaquim FERNANDEZ-SOLA Giovanni ADDOLORATO Philippe DE WITTE Esa KORPI Henriette WALTER Mickael NAASSILA (Amiens), Chair Olivier PIERREFICHE (Amiens), Deputy Chair Olivier COTTENCIN (Lille), Deputy Chair Elodie PECOURT, (Amiens), Secretary   Bernard ANGERVILLE (Amiens) Henri-Jean AUBIN (Paris) Christelle BAUNEZ (Marseille) Hélène BEAUNIEUX (Caen) Amine BENYAMINA (Paris) Régis BORDET (Lille) Georges

mars 21, 2019

janvier 16, 2019

janvier 16, 2019

septembre 4, 2018

PLATINUM sponsor: CHEPLAPHARM is a pharmaceutical company headquartered in Greifswald, Germany, offering branded and niche products in more than 120 countries worldwide. The company’s portfolio includes medications for various indications, including methadone, which is used in the treatment of opioid dependence. CHEPLAPHARM adheres to international addictions guidelines to ensure the safe and effective use of